‘Complete Response’ Letters
Details of action letters issued by FDA, regularly updated with new announcements.
You may also be interested in...
Lack of readiness derails eye drugs from Valeant and Ocular, which now must convince FDA they know what they are making; meanwhile, an expert shares how mistake-proofing processes can help.
The European Commission has updated its figures on the status of readiness of notified bodies under the Medical Device and IVD Regulations. Three more designations are imminent, but just one under the IVDR.
Salus Haus has expanded its popular Floradix range with an immunity boosting liquid supplement and a children's verison of its flagship Floradix Liquid product.